BIOTRONIK Neuro acquires Soin Neuroscience’s SCS IP portfolio

BIOTRONIK Neuro has acquired a portfolio of IP from Soin Neuroscience related to spinal cord stimulation (SCS) technology. The acquisition follows a previous research collaboration between Soin Neuroscience and BIOTRONIK Neuro in December 2025. BIOTRONIK Neuro plans to use the IP as part of its efforts to develop a next-generation spinal cord stimulation programme. Credit: sasirin pamai / Shutterstock.com. BIOTRONIK Neuro has purchased a portfolio of intellectual property (IP) from Soin Neuroscience related to spinal cord stimulation (SCS) technology. The patents obtained cover several areas, including SCS waveform design, adaptive programming, and the integration of machine learning and AI in…

Source: Medical Device Network